SCIENTIFIC ADVISORY BOARD

PRAVIN DUGEL
MD
Co-Chair of
Scientific Advisory Board
PRESENTATION

Managing Partner of Retinal Consultants of Arizona, Founding Member of the Spectra Eye Institute and Clinical Professor at the Department of Ophthalmology at the Keck School of Medicine, University
of Southern California. Globally recognized as a clinical researcher, having served as Principal Investigator for over 100 multicenter clinical trials for emerging and FDA-approved therapies for wet age-related macular degeneration including Beovu®, Lucentis® and Eylea®. Dr. Dugel has authored more than 200 papers and 35 book chapters. He is on the Editorial Board of several major medical journals.

ERIC DONNENFELD
MD
Co-Chair of
Scientific Advisory Board
PRESENTATION
Trustee of Dartmouth Medical School and a clinical professor of ophthalmology at New York University. He is past president of American Society of Cataract and Refractive Surgery, president-elect of the International Intraocular Implant Society and is the editor-in-chief of EyeWorld. He has written over 200 peer review papers and 60 book chapters and books. He is a Fellow of the American Academy
of Ophthalmology and has received its Lifetime Achievement Award.
CHRISTOPHE BAUDOUIN
MD
Member of
Scientific Advisory Board
PRESENTATION

Christophe Baudouin is professor of Ophthalmology since 1995. He is chairman of the department of Ophthalmology III in Quinze-Vingts National Ophthalmology Hospital, Paris, president of the Medical Council since 2016. Since 2008 he is also the Director of an INSERM-labelled research group, located in Vision Institute, Sorbonne University, a research center dedicated to ophthalmology. He is currently the president of the European Dry Eye Society, Editor-in-chief of the French Journal of Ophthalmology, vice-president of the French Glaucoma Society, and active member of several international societies, including the prestigious American Ophthalmological Society and Academia Ophthalmologica Internationalis, as well as member of the board of the International Council of Ophthalmology (ICO).

EDWARD J. HOLLAND
MD
Member of
Scientific Advisory Board
PRESENTATION

Edward J. Holland, MD is the Director of Cornea Services at Cincinnati Eye Institute and Professor of Ophthalmology at the University of Cincinnati. He attended the Loyola-Stritch School of Medicine in Chicago and trained in Ophthalmology at the University of Minnesota. He completed a fellowship in cornea and external disease at the University of Iowa, and then completed a second fellowship in ocular immunology at the National Eye Institute, National Institutes of Health in Bethesda, Maryland.

Dr. Holland was a former member of the Board of Trustees for the American Academy of Ophthalmology and received both the Senior Achievement Award and Life Achievement Honor Award from the AAO. He also served as the President of American Society of Cataract and Refractive Surgery and presently serves as the Program Chair. He received the ASCRS top award, the Binkhorst Medal, in 2008 and the inaugural Lindstrom Medal in 2020.  Dr. Holland has served as the Chair of the Eye Bank Association and was the former Chair of their Medical Advisory Board. He was a recipient of the 2002 Paton Society Award given by the EBAA. Dr. Holland is a past President of the Cornea Society and previously served on its Board of Directors for over 20 years. He was awarded the Castroviejo Award from the Cornea Society in 2013. Dr. Holland was awarded the Asian Cornea Foundation Medal of Honor in 2016.

Dr. Holland has published extensively in both basic and clinical research and is the author of over 250 articles in peer review journals. He has co-edited five editions of Cornea, the most widely read textbook on corneal disease and surgery.

SABRI MARKABI
MD
Member of
Scientific Advisory Board
PRESENTATION
Dr. Sabri Markabi is the former global Head of R&D and CMO of Alcon, and has worked in the pharmaceutical industry for more than 20 years in global drug development leadership positions. In particular, he headed the clinical Neuroscience department then the Global Ophthalmics Development group at Novartis Pharma before joining Alcon, the pharmaceutical and medical device ophthalmology leader, where he worked between 2008 and 2015. Since 2016, he has advised health care organizations on topics including investment and R&D strategy and is a member of the Board of Director of MedinCell, Inc.
EINAR STEFÁNSSON
MD
Member of
Scientific Advisory Board
PRESENTATION
Dr. Stefánsson is a leading physician in the field of diabetic eye disease and diabetic eye screening. Dr. Stefánsson has co-founded four biotechnology firms in addition to Oculis, including Cyclops ehf. which was acquired by DeCode Genetics in 2000. He contributes to a number of ophthalmological publications either as chief editor or on the editorial board. Dr. Stefánsson was knighted by the President of Iceland in 2007 and received a number of awards in science and ophthalmology, such as Iceland’s highest award in science in 2008 and the gold medal of the European Academy of Ophthalmology in 2014 among many other honours. Dr. Stefánsson has published more than 300 peer-reviewed international publications, more than 400 abstracts, numerous book chapters and patents. Dr. Stefánsson received a degree in medicine from the University of Iceland Medical School and a Ph.D. in physiology from Duke University followed by a residency and faculty position at Duke. He has served as Vice Dean and Dean of the Faculty of Medicine at the University of Iceland and served as Professor and Chair of the Department of Ophthalmology at the National University Hospital in Iceland since 1993.
RAMIN TADAYONI
MD
Member of
Scientific Advisory Board
PRESENTATION
Professor of Ophthalmology at University of Paris and Head of the department of Ophthalmology at Lariboisière University Hospital (Paris, France). He has authored more than 140 medical and scientific articles and has made numerous contributions to ophthalmology textbooks. Dr. Tadayoni completed undergraduate training in medicine at the University of Marseille, and his M.D. and internship at Paris V University. He completed his studies with a retina fellowship at Lariboisière University Hospital. Simultaneously, he pursued his Ph.D. in Science at Paris VII University and the Paris Vision Institute.